Why Your Diagnostic Tests can be Vital A blood test can mean the difference between life and death. Hard-hitting as it sounds, diagnostic tests provide results that can change an individual’s life and allow health professionals to diagnose and then treat their conditions.Diagnostic tests are a key component in virtually every health intervention that takes place. The results of these tests provide essential and invaluable information throughout the healthcare process, with tests being...

BIVDA launches the Don’t Wait;Act Testing Campaign For Immediate Release  -- BIVDA, the trade association for British in-vitro diagnostic companies, has launched its new Don’t Wait;Act campaign to re-start testing for non-COVID health issues today. Routine care and health screening for diseases such as cancers, heart disease and diabetes have either experienced long pauses or drops in take-ups from members of the public during the COVID-19 pandemic. As a result, t...

BIVDA was pleased to welcome Dr Alessandro Carabelli, Research Lead from COG-UK, to the most recent meeting of the APPG for Life Sciences. Dr Carabelli presented on the progress of identifying and testing for new COVID-19 variants, and he is pleased for us to share his slides for interest - you can find them attached below. 

Please find attached update presentations from the MDCC on border controls and batch testing. 

The MDCC Unit in the Office for Life Sciences has put together a Q&A document covering an extensive range of issues including UKCA marking, cross-border trade and packaging requirements. Members can find it attached.

A new vision for the delivery of clinical research has been announced by the Government which is designed to improve the processes through which researchers can design and deliver their work. The vision will strengthen the UK’s renowned expertise in the research area and its position as a world-class country in terms of research standards. It is expected that patients and staff will benefit greatly from having research dedicated towards the improvement of their experiences in the NHS being...

BIVDA welcomes new Government research strategy BIVDA, the trade association for British in-vitro diagnostic companies, has welcomed the publication of the Government’s new research strategy ‘Saving and improving lives: the future of UK clinical research delivery’. The strategy sets out plans to strengthen the UK’s renowned expertise as a world-leader in designing and delivering medical and scientific research. It is built around 5 key themes:  Clinical research...

Three new Lighthouse Lab testing facilities have opened in Brants Bridge, Baltic Park and Plymouth, adding to the list of test processing sites across the United Kingdom. These labs will be working in partnership with NHS Test and Trace to identify new cases of coronavirus, thus ensuring that the chains of transmission are broken in communities. The labs are managed by local NHS trusts, and form the largest network of diagnostic facilities ever set about in British history. The Lighthouse Labora...

A new independent review has been launched by the Science Minister Amanda Solloway into how red tape can be cut to allow researchers to carry out their work better. The review will identify hurdles of UK research bureaucracy that hold the UK back in terms of securing a world-class research output. The study will be led by Professor Adam Tickell, Vice Chancellor at University of Sussex and delivers on the commitment by the UK Government in the strategic Research and Development Roadmap to minimis...

BIVDA Welcomes new EUCOPE – Charles River Associates report on advanced diagnostics  BIVDA, the UK trade association for in-vitro diagnostic companies, has welcomed the publication of a White Paper on Advanced Diagnostics by EUCOPE and Charles River Associates that puts forward concrete proposals to support understanding of the advanced diagnostics sector, the benefits it brings and related requirements for success . The health benefits of genomics and advanced genomic testing ar...